NTRK1 and nasopharyngeal carcinoma: To investigate whether VIRMA exerts its tumor-promoting function through upregulating ITGA2, ITGA5, and NTRK1 expression, we performed in vitro functional experiments by overexpressing ITGA2, ITGA5, or NTRK1 in VIRMA-silenced NPC cells.